Can Lexapro (escitalopram) cause nosebleeds?

Can Lexapro Cause Nosebleeds?

Yes, Lexapro (escitalopram) can cause nosebleeds—this is a recognized adverse effect documented in both FDA labeling and clinical literature, occurring through the drug's effect on platelet serotonin function.

Mechanism and Evidence

Lexapro, as an SSRI, interferes with serotonin reuptake in platelets, which impairs platelet aggregation and increases bleeding risk 1. The FDA label explicitly lists epistaxis (nosebleed) as an adverse reaction and warns that "drugs that interfere with serotonin reuptake inhibition, including Lexapro, increase the risk of bleeding events" 1. Bleeding events can range from minor manifestations like epistaxis and ecchymoses to life-threatening hemorrhages 1.

In pediatric clinical trials specifically, epistaxis was significant enough to cause treatment discontinuation in 1% of patients aged 7-17 years with generalized anxiety disorder (compared to 0% on placebo) 1. This demonstrates that nosebleeds can be clinically meaningful, not just a theoretical concern.

Clinical Context and Risk Factors

The bleeding risk is not isolated to Lexapro alone—it's a class effect of SSRIs 2, 3, 4. A case report documented escitalopram-induced epistaxis in a patient with seasonal allergic rhinitis, highlighting that pre-existing nasal conditions may increase susceptibility 2. The risk substantially increases when Lexapro is combined with:

• Antiplatelet agents (aspirin, clopidogrel)
• Anticoagulants (warfarin, DOACs)
• NSAIDs 1

The FDA label specifically instructs clinicians to "inform patients about the increased risk of bleeding associated with the concomitant use of Lexapro and antiplatelet agents or anticoagulants" 1.

Management Approach

If a patient on Lexapro develops epistaxis, do NOT automatically discontinue the medication. Following epistaxis management guidelines, the priority is first-line local control measures 5:

1. Immediate first-line interventions:

   • Nasal compression (pinch soft part of nose for 5-15 minutes)
   • Topical vasoconstrictors (oxymetazoline spray)
   • Nasal saline for moisturization
   • Chemical or electrical cautery if bleeding site identified

2. Medication assessment:

   • Review all concurrent medications that affect hemostasis
   • Contact the prescribing psychiatrist before stopping Lexapro, as the medication is typically treating serious psychiatric conditions
   • Do not reverse or withhold psychiatric medications unless bleeding is life-threatening 5

3. Risk stratification:

   • Most SSRI-related epistaxis is mild to moderate and responds to conservative measures 3
   • Severe cases requiring invasive intervention (packing, surgery, embolization) are uncommon but documented 3

Key Clinical Pitfalls

• Don't assume the nosebleed is unrelated to medication—SSRIs are an often-neglected cause of epistaxis 3
• Don't stop Lexapro precipitously—the psychiatric condition being treated may pose greater risk than the nosebleed itself
• Don't overlook drug interactions—concurrent use of NSAIDs, aspirin, or anticoagulants dramatically amplifies bleeding risk 1
• Don't ignore recurrent epistaxis—this warrants medication review and possible dose adjustment or alternative antidepressant selection

Documentation and Follow-up

For patients experiencing medication-related epistaxis, document the adverse effect and consider pharmacovigilance reporting 3. If epistaxis is recurrent or severe, consultation with both psychiatry (for alternative antidepressant options) and otolaryngology (for anatomic assessment and advanced hemostatic interventions) may be warranted.